DCRI staff are praised as industry leaders in new ISR quality benchmarking report

April 24, 2013 – The fifth annual report surveyed more than 150 professional about their experiences with small, mid-sized, and large CROs that provide Phase II/Phase III research.

In a new Clinical Research Organization (CRO) quality benchmarking report from Industry Standard Research (ISR), DCRI staff are highlighted as industry leaders for therapeutic expertise.

The report, “2013 CRO Quality Benchmarking Phase II/Phase III Service Providers”, is the 5th annual quality benchmarking report from ISR. It surveyed more than 150 pharmaceutical professionals about their experiences with approximately 30 small, mid-size, and large CROs that handle Phase II/Phase III research.